Biology:Rickettsia helvetica

From HandWiki
Revision as of 02:50, 11 March 2023 by Scavis2 (talk | contribs) (update)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Species of bacterium

Rickettsia helvetica
Scientific classification edit
Domain: Bacteria
Phylum: Pseudomonadota
Class: Alphaproteobacteria
Order: Rickettsiales
Family: Rickettsiaceae
Genus: Rickettsia
Species group: Spotted fever group
Species:
R. helvetica
Binomial name
Rickettsia helvetica
Beati, Peter, Burgdorfer, Aeschlirnami & Raoult, 1993[1]

Rickettsia helvetica,[2] previously known as the Swiss agent, is a bacterium found in Dermacentor reticulatus and other ticks, which has been implicated as a suspected but unconfirmed human pathogen.[3][4][5] First recognized in 1979 in Ixodes ricinus ticks in Switzerland (hence the designation helvetica) as a new member of the spotted fever group of Rickettsia, the R. helvetica bacterium was eventually isolated in 1993.[6] Although R. helvetica was initially thought to be harmless in humans and many animal species, some individual case reports suggest that it may be capable of causing a nonspecific fever in humans.[4][5][7] In 1997, a man living in eastern France seroconverted to Rickettsia 4 weeks after onset of an unexplained febrile illness.[8] In 2010, a case report indicated that tick-borne R. helvetica can also cause meningitis in humans.[9]

Molecular evidence suggests that in Croatia, as many as 10% of D. reticulatus ticks are infected with R. helvetica.[10] In addition to this, R. slovaca[11] is found in another 2%, and 1% are infected with both species.[12]

Signs and symptoms

Erythema migrans or rash was observed at all combinations of seroreactivity, with symptoms including fever, muscle pain, headache, and respiratory problems.[13]

The spots (erythema migrans) are described as red spots, much lesser in size than those seen in Lyme disease, but sometimes no spots occur at all.[14]

Epidemiology

In 80 healthy Swedish blood donors, about 1% were seroreactive for Rickettsia spp., interpreted as past infection. In a prospective study of Swedish recruits who trained in the coastal areas, 8.9% showed seroconversion[13]

Treatment

As with other rickettsioses, the treatment of choice is doxycycline[15]

See also

References

  1. Xue-Jie Yu; David H. Walker (2005). "Genus I. Rickettsia da Rocha Lima 1916, 567". The proteobacteria, Part 3. Bergey's Manual of Systematic Bacteriology. 2 (2 ed.). Springer. pp. 96–114. ISBN 978-0-387-24145-6. https://books.google.com/books?id=9cwgo-9IyTUC&pg=PA109. 
  2. "Rickettsia helvetica". http://medical-dictionary.thefreedictionary.com/Rickettsia+helvetica. 
  3. Piller, Charles (October 12, 2016). "The 'Swiss Agent': Long-forgotten research unearths new mystery about Lyme disease". https://www.statnews.com/2016/10/12/swiss-agent-lyme-disease-mystery/. 
  4. 4.0 4.1 Parola, P.; Davoust, B.; Raoult, D. (2005). "Tick- and flea-borne rickettsial emerging zoonoses". Veterinary Research 36 (3): 469–492. doi:10.1051/vetres:2005004. PMID 15845235. https://hal.archives-ouvertes.fr/hal-00902973/file/hal-00902973.pdf. 
  5. 5.0 5.1 Walker, D. H. (2007). "Rickettsiae and Rickettsial Infections: The Current State of Knowledge". Clinical Infectious Diseases 45: S39–S44. doi:10.1086/518145. PMID 17582568. 
  6. Beati, L.; Péter, O.; Burgdorfer, W.; Aeschlimann, A.; Raoult, D. (1993). "Confirmation that Rickettsia helvetica sp. nov. Is a distinct species of the spotted fever group of rickettsiae". International Journal of Systematic Bacteriology 43 (3): 521–526. doi:10.1099/00207713-43-3-521. PMID 8102245. 
  7. Dobler, G.; Wölfel, R. (2009). "Typhus and other rickettsioses: Emerging infections in Germany". Deutsches Ärzteblatt International 106 (20): 348–354. doi:10.3238/arztebl.2009.0348. PMID 19547738. 
  8. Fournier, P. E.; Grunnenberger, F.; Jaulhac, B.; Gastinger, G.; Raoult, D. (2000). "Evidence of Rickettsia helvetica infection in humans, eastern France". Emerging Infectious Diseases 6 (4): 389–392. doi:10.3201/eid0604.000412. PMID 10905974. 
  9. Nilsson, K.; Elfving, K.; Pahlson, C. (2010). "Rickettsia helvetica in Patient with Meningitis, Sweden, 2006". Emerging Infectious Diseases 16 (3): 490–492. doi:10.3201/eid1603.090184. PMID 20202426. 
  10. Dobec, M.; Golubic, D.; Punda-Polic, V.; Kaeppeli, F.; Sievers, M. (2009). "Rickettsia helvetica in Dermacentor reticulatus ticks". Emerging Infectious Diseases 15 (1): 98–100. doi:10.3201/eid1501.080815. PMID 19116063. 
  11. "Rickettsia slovaca". https://medical-dictionary.thefreedictionary.com/Rickettsia+slovaca. 
  12. "Rickettsia helvetica in Ticks | CDC EID". Cdc.gov. 2008-12-23. https://www.cdc.gov/eid/content/15/1/98.htm. 
  13. 13.0 13.1 Lindblom, A.; Wallménius, K.; Nordberg, M.; Forsberg, P.; Eliasson, I.; Påhlson, C.; Nilsson, K. (2012). "Seroreactivity for spotted fever rickettsiae and co-infections with other tick-borne agents among habitants (sic) in central and southern Sweden". European Journal of Clinical Microbiology & Infectious Diseases 32 (3): 317–323. doi:10.1007/s10096-012-1742-3. PMID 22961007. 
  14. "Fästingar sprider fläcktyfus". http://www.gp.se/nyheter/sverige/1.1067910-fastingar-sprider-flacktyfus. 
  15. Botelho-Nevers E, Socolovschi C, Raoult D, Parola P. Treatment of Rickettsia spp. infections: a review. Expert Rev Anti Infect Ther 2012; 10:1425–1437

Wikidata ☰ Q7331933 entry